Valuation Simcere Pharmaceutical Group Limited

Stocks

Market Closed - Hong Kong S.E. Other stock markets 04:08:13 2026-08-07 EDT			5-day change	1st Jan Change
12.45 ^HKD	+1.55%		+0.81%	+4.01%

07-30	Simcere Pharmaceutical Group Limited Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2026	CI
07-09	Simcere Pharma's Acute Ischemic Stroke Included in National Essential Medicines List	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	3,030	3,965	2,254	2,273	3,992	4,076	-	-
Change	-	30.84%	-43.14%	0.81%	75.65%	2.1%	-	-
Enterprise Value (EV) ¹	2,944	3,802	2,173	2,151	3,637	3,889	3,953	4,057
Change	-	29.15%	-42.86%	-1%	69.08%	6.93%	1.65%	2.63%
P/E	12.6x	28.6x	22.6x	23x	19.9x	16.1x	14x	12x
PBR	2.97x	3.84x	2.21x	2.37x	2.84x	2.63x	2.33x	2.09x
PEG	-	-0.8x	-0.9x	3.11x	0.2x	0.7x	0.9x	0.7x
Capitalization / Revenue	3.86x	4.31x	2.46x	2.48x	3.56x	2.73x	2.41x	1.99x
EV / Revenue	3.75x	4.13x	2.37x	2.35x	3.24x	2.6x	2.34x	1.98x
EV / EBITDA	11x	24.1x	15.3x	13.2x	12.9x	12.1x	10.3x	9.16x
EV / EBIT	16.5x	30.3x	22x	18.4x	16.1x	11.7x	12.8x	10.5x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ³	0.15	0.16	0.16	0.16	0.18	0.354	0.4075	0.4751
Rate of return	2.05%	1.56%	2.62%	2.4%	1.67%	3.31%	3.81%	4.44%
EPS ³	0.58	0.36	0.27	0.29	0.54	0.6656	0.7649	0.8941
Distribution rate	25.9%	44.4%	59.3%	55.2%	33.3%	53.2%	53.3%	53.1%
Net sales ¹	785.2	919.9	917.9	915.2	1,122	1,495	1,688	2,048
EBITDA ¹	267	158.1	141.9	163.5	280.9	321.1	383.3	442.7
EBIT ¹	178.1	125.6	98.87	117	225.7	331.3	307.8	386.1
Net income ¹	236.7	135.8	99.28	101.1	188.8	246.1	292.4	347.3
Net Debt ¹	-85.96	-162.3	-81.83	-121.8	-355.3	-186.9	-122.6	-18.49
Reference price ³	7.32	10.28	6.11	6.67	10.76	10.71	10.71	10.71
Nbr of stocks (in thousands)	2,628,291	2,660,377	2,616,723	2,486,321	2,595,698	2,568,199	-	-
Announcement Date	3/24/22	3/31/23	3/20/24	3/24/25	3/25/26	-	-	-

¹CNY in Million²USD in Million³CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
SIMCERE PHARMACEUTICAL GROUP LIMITED	16.09x	2.6x	12.11x	3.31%	4.08B
SUN PHARMACEUTICAL INDUSTRIES LTD.	35.76x	6.74x	23.33x	0.88%	49.03B
OTSUKA HOLDINGS CO., LTD.	20.02x	2.36x	10.74x	1.29%	42.33B
CIPLA LIMITED	28.49x	3.47x	18x	0.89%	12.43B
ZYDUS LIFESCIENCES LIMITED	26.41x	3.9x	15.87x	0.6%	11.68B
KRKA, D. D.	19.07x	3.33x	11.97x	3.49%	9.12B
GEDEON RICHTER	8.6x	2.03x	5.32x	5.04%	7.15B
ONO PHARMACEUTICAL CO., LTD.	15.67x	2.02x	6.32x	3.29%	7.09B
GLENMARK PHARMACEUTICALS LIMITED	34.6x	3.94x	16.78x	0.23%	6.76B
Average	22.75x	3.38x	13.38x	2.11%	16.63B
Weighted average by Cap.	26.12x	4.11x	15.79x	1.48%